Researchers report that engineered exosomes can deliver regenerative cargo directly to neural stem cells after spinal cord injury, aiming to improve functional repair in a setting defined by chronic inflammation and failed circuit reconstruction. The preclinical concept pairs vesicle targeting with cell-state support after injury. If subsequent studies confirm safety and effect size, exosome-mediated delivery could become a modular platform for spinal cord repair trials, leveraging tissue targeting and payload engineering rather than relying solely on biomaterials or cell transplantation.